$5.41 +0.10 (%) Arrowhead Pharmaceuticals Inc - NASDAQ

Jun. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Mid-Day Market Update: Breitburn Energy Partners Drops Following News of Distribution Suspension; Mattress Firm Shares Surge

    Benzinga | Dec. 1, 2015 | 12:03PM EST
  2. Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA

    Benzinga | Nov. 16, 2015 | 11:02AM EST
  3. US Stock Futures Edge Higher Ahead Of Empire State Manufacturing Index

    Benzinga | Nov. 16, 2015 | 07:07AM EST
  4. Arrowhead Presents Positive Data on ARC-520 in Hepatitis B Infected Chimpanzees at AASLD Liver Meeting 2015

    Benzinga | Nov. 15, 2015 | 18:43PM EST
  5. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 13, 2015 | 08:17AM EST
  6. 10 Stocks Moving In Monday's After-Hours Session

    Benzinga | Sep. 28, 2015 | 16:47PM EST
  7. Arrowhead's good test result

    IBD | Sep. 24, 2015 | 18:35PM EST
  8. Arrowhead Hits Target In Hepatitis B Drug Trial

    IBD | Sep. 24, 2015 | 10:51AM EST
  9. Mid-Morning Market Update: Markets Tumble; Accenture Tops Q4 Estimates

    Benzinga | Sep. 24, 2015 | 10:33AM EST
  10. Morning Market Gainers

    Benzinga | Sep. 24, 2015 | 09:41AM EST
  11. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 24, 2015 | 08:08AM EST
  12. Morning Market Gainers

    Benzinga | Sep. 11, 2015 | 09:48AM EST
  13. Arrowhead Initiates Dosing of ARC-AAT in Patients with Alpha-1 Antitrypsin Deficiency

    Benzinga | Jul. 2, 2015 | 07:33AM EST
  14. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  15. Arrowhead Receives Regulatory Clearance to Begin Additional Phase 2b Studies of Hepatitis B Candidate ARC-520

    Benzinga | Jun. 17, 2015 | 07:30AM EST
  16. Arrowhead Presents Data on Potential RNAi Candidate Targeting Factor 12 Mediated Angioedemic and Thromboembolic Diseases

    Benzinga | May. 6, 2015 | 15:19PM EST
  17. Morning Market Losers

    Benzinga | Apr. 14, 2015 | 09:52AM EST
  18. Morning Market Gainers

    Benzinga | Apr. 13, 2015 | 09:41AM EST
  19. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 13, 2015 | 08:12AM EST
  20. The News That Should Move Arrowhead Research Today

    Benzinga | Feb. 10, 2015 | 07:09AM EST
  21. Arrowhead Research Shares Seeing Significant Short Interest

    Benzinga | Feb. 2, 2015 | 11:46AM EST
  22. Deutsche Bank Downgrades Arrowhead, Says 2015 Is The 'Show-Me Year'

    Benzinga | Jan. 22, 2015 | 09:22AM EST
  23. Mid-Day Market Update: Foundation Medicine Shares Jump Following Deal With Roche; Crude Oil Slides Over 4%

    Benzinga | Jan. 12, 2015 | 12:55PM EST
  24. Mid-Morning Market Update: Markets Tumble; Shire To Acquire NPS Pharmaceuticals For $5.2 Billion

    Benzinga | Jan. 12, 2015 | 11:37AM EST
  25. Morning Market Losers

    Benzinga | Jan. 12, 2015 | 09:54AM EST
  26. Merger Monday Moving Stocks Monday Morning

    Benzinga | Jan. 12, 2015 | 09:48AM EST
  27. Arrowhead Research Tumbles 20% Following FDA News

    Benzinga | Jan. 12, 2015 | 09:13AM EST
  28. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 12, 2015 | 08:15AM EST
  29. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 2, 2015 | 08:38AM EST
  30. Biotech Stocks Make Big Moves In Final Days Of 2014

    Benzinga | Dec. 31, 2014 | 09:41AM EST
  31. Arrowhead Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi Therapeutic ARC-AAT

    Benzinga | Nov. 18, 2014 | 07:30AM EST
  32. Arrowhead Offers Data on ARC-520, ARC-AAT at AASLD The Liver Meeting

    Benzinga | Nov. 10, 2014 | 09:18AM EST
  33. Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR

    GuruFocus | Oct. 20, 2014 | 11:40AM EST
  34. The 3 Most Volatile Biotech Stocks

    Benzinga | Oct. 14, 2014 | 12:42PM EST
  35. Arrowhead Research Corp Hammered On Drug News; Deutsche Bank Lowers Price Target

    Benzinga | Oct. 8, 2014 | 14:32PM EST
  36. Midday Losers From October 8 - Arrowhead Research Corp, A10 Networks Inc. And More

    Benzinga | Oct. 8, 2014 | 13:49PM EST
  37. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
  38. Arrowhead Research Corp Down Big On Disappointing Hepatitis B Drug Data

    Benzinga | Oct. 8, 2014 | 11:41AM EST
  39. Morning Market Losers

    Benzinga | Oct. 8, 2014 | 09:48AM EST
  40. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 8, 2014 | 08:09AM EST
  41. Top 5 Biotech Stocks Over The Past Year

    Benzinga | Oct. 6, 2014 | 14:28PM EST
  42. Arrowhead Research Corp Heads Higher After Breakout

    Benzinga | Sep. 4, 2014 | 14:51PM EST
  43. Arrowhead Research Corp Shares Push Over Resistance Level As Momentum Continues

    Benzinga | Sep. 3, 2014 | 12:54PM EST
  44. Winners & Losers From Tuesday, August 26

    Benzinga | Aug. 26, 2014 | 16:02PM EST
  45. Deutsche Bank Sees Achillion, Arrowhead As Potential Takeover Targets

    Benzinga | Aug. 26, 2014 | 13:37PM EST
  46. Morning Market Movers

    Benzinga | Jul. 29, 2014 | 09:42AM EST
  47. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 29, 2014 | 08:13AM EST
  48. Arrowhead Research Up Over 6% Following CNBC Comments

    Benzinga | Jul. 9, 2014 | 11:51AM EST
  49. 4 Biotech Stocks With Big Money Coming In

    Benzinga | Jun. 30, 2014 | 15:50PM EST
  50. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 19, 2014 | 08:13AM EST
Trading Center